Finland· FI-REL-REL24685
Avaglim
A glimepiride and rosiglitazone product containing rosiglitazone + glimepiride, registered in Finland by SmithKline Beecham Ltd. The same ATC class is registered in 2 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Glimepiride and rosiglitazone is registered in 2 of 19 countries.
Countries holding a registration under ATC A10BD04 (glimepiride and rosiglitazone), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 1 of them publish a price we can compare per daily dose
Glimepiride and rosiglitazone · ATC A10BD04
2 / 19 countries
- Denmark
- Finlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Rosiglitazone + Glimepiride
- Manufacturer
- SmithKline Beecham Ltd
- Country
- Finland (FI)
- ATC code
- A10BD04
- ATC class
- Glimepiride and rosiglitazone
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A10BD04
Glimepiride and rosiglitazone, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6bbd4c50-12fc-4e55-8fd8-04e601cf3264 GET /v1/drugs/6bbd4c50-12fc-4e55-8fd8-04e601cf3264?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "1",
"form": "tabletti, kalvopäällysteinen",
"route": null,
"ddd_unit": "ED",
"strength": "4 mg / 4 mg",
"atc_label": "glimepiridi ja rosiglitatsoni",
"ma_number": null,
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": "EU/1/06/349/1-4,9",
"fimea_rel_id": "REL24685",
"authorised_at": "2006-06-27"
}See everything about glimepiride and rosiglitazone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.